The potential link between atherosclerosis and the 5-lipoxygenase pathway: investigational agents with new implications for the cardiovascular field

Author： Whatling Carl   McPheat William   Herslöf Margareta  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.16, Iss.12, 2007-12, pp. : 1879-1893

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibitors of the 5-Lipoxygenase Pathway in Atherosclerosis

By  

Current Pharmaceutical Design, Vol. 15, Iss. 27, 2009-09 ,pp. : 3116-3132

Bentham Science Publishers

Access to resources Recommend Favorite

5-Lipoxygenase, Leukotrienes Biosynthesis and Potential Antileukotrienic Agents

By  

Current Medicinal Chemistry, Vol. 13, Iss. 2, 2006-01 ,pp. : 117-129

Bentham Science Publishers

Access to resources Recommend Favorite

Tissue factor pathway inhibitor: an update of potential implications in the treatment of cardiovascular disorders

By Hoppensteadt Debra A   Kaiser Brigitte   Fareed Jawed  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 11, 2001-11 ,pp. : 1925-1935

Informa Healthcare

Access to resources Recommend Favorite

5-Lipoxygenase in the Central Nervous System: Therapeutic Implications

By  

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 1, Iss. 2, 2002-09 ,pp. : 115-121

Bentham Science Publishers

Access to resources Recommend Favorite

New investigational antifungal agents for treating invasive fungal infections

By Hossain M.A.   Ghannoum M.A.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 8, 2000-08 ,pp. : 1797-1813

Informa Healthcare

Access to resources Recommend Favorite